Skip to content
Screener

Staar Surgical STAA Common Stock

Common Stock at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Bausch Health Companies logo
Bausch Health CompaniesBHC
$10.54B+0.3%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$121K+2.5%
IAR
Integra LifeSciencesIART
240M0.0%
Schering-Plough logo
Schering-PloughSGP
154.4M0.0%
Glaukos logo
GlaukosGKOS
$59K+3.5%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.25B-7.5%
Enterprise value$1.16B-5.7%
P/S4.3×-1.7×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemApril 3, 2026January 2, 2026
Total liabilities98,752107,494
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.01 par value; 60,000 shares authorized: 50,156 shares issued and 49,780 shares outstanding at April 3, 2026 and 49,779 shares issued and 49,403 outstanding at January 2, 2026502498
Additional paid-in capital507,921504,682
Treasury stock, 376 and 376 shares at April 3, 2026 and January 2, 2026, respectively(6,461)(6,461)
Accumulated other comprehensive loss(6,778)(6,511)
Accumulated deficit(142,818)(148,024)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's common stock?
Staar Surgical (STAA) reported common stock of $502K in Q1 2026.
How has Staar Surgical's common stock changed year-over-year?
Staar Surgical's common stock increased by 1.4% year-over-year, from $495K to $502K.
What is the long-term trend for Staar Surgical's common stock?
Over 5 years (2020 to 2025), Staar Surgical's common stock has grown at a 1.4% compound annual growth rate (CAGR), from $464K to $498K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Staar Surgical's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude